Published in Diabetes Care on May 01, 2011
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care (2013) 2.96
Adherence to therapies in patients with type 2 diabetes. Diabetes Ther (2013) 2.23
Diabetes: Clinical inertia--a barrier to effective management of T2DM. Nat Rev Endocrinol (2013) 0.84
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06
A strategy to reduce cardiovascular disease by more than 80%. BMJ (2003) 19.05
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract (1995) 12.51
Clinical inertia. Ann Intern Med (2001) 11.14
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet (2009) 10.55
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (2010) 9.20
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med (2009) 4.53
Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med (2002) 3.90
Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care (2005) 3.02
Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care (2008) 2.52
Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med (2004) 2.06
Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care (2003) 2.00
How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med (2002) 1.84
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis (2009) 1.35
Megatrials in type 2 diabetes. From excitement to frustration? Diabetologia (2009) 1.28
The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach. Diabetes Metab Res Rev (2010) 1.28
Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract (2005) 1.27
Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea. Ann Pharmacother (2010) 1.14
Overcoming barriers to evidence-based diabetes care. Curr Diabetes Rev (2006) 0.98
The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis (2008) 0.92
Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am J Med (2010) 0.91
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. Br J Clin Pharmacol (2006) 0.79
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest (2007) 5.02
How do we define cure of diabetes? Diabetes Care (2009) 3.59
Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A (2007) 3.11
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial. Diabetes Care (2011) 2.96
Management of type 2 diabetes: new and future developments in treatment. Lancet (2011) 2.57
Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes (2005) 2.47
Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem (2007) 2.20
Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis (2005) 2.01
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab (2004) 1.66
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care (2013) 1.56
Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study. Atherosclerosis (2007) 1.50
Alpha-adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria. J Hypertens (2006) 1.46
Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes (2002) 1.34
The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach. Diabetes Metab Res Rev (2010) 1.28
Normal glucose tolerance and gestational diabetes mellitus: what is in between? Diabetes Care (2007) 1.18
ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. Endocr Pract (2006) 1.12
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis (2011) 1.11
Changing the treatment paradigm for type 2 diabetes. Diabetes Care (2009) 1.10
Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care (2005) 1.09
Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study. Nephrol Dial Transplant (2011) 1.08
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes (2003) 1.08
Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism. Diabetes (2002) 1.07
Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells. FASEB J (2004) 1.07
Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl Int (2005) 1.06
Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome. Atherosclerosis (2004) 1.05
The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol (2006) 1.04
Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens (2014) 1.04
Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Care (2011) 1.03
Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol (2004) 1.02
Beta-cell failure in type 2 diabetes mellitus. Curr Diab Rep (2008) 1.02
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis (2007) 0.98
Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol (2003) 0.98
Metabolic memory and individual treatment aims in type 2 diabetes--outcome-lessons learned from large clinical trials. Rev Diabet Stud (2011) 0.97
Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study. Am J Hypertens (2009) 0.96
Low-grade inflammation and microalbuminuria in hypertension. Arterioscler Thromb Vasc Biol (2004) 0.95
Left ventricular function in normotensive young adults with well-controlled type 1 diabetes mellitus. Am J Cardiol (2006) 0.95
Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. J Diabetes Complications (2005) 0.94
Treating the metabolic syndrome. Expert Rev Cardiovasc Ther (2007) 0.93
Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab (2004) 0.93
Primary prevention of cardiovascular disease in people with dysglycemia. Diabetes Care (2008) 0.93
The pancreatic beta-cell in human Type 2 diabetes. Nutr Metab Cardiovasc Dis (2006) 0.92
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol (2014) 0.92
Early subclinical atherosclerosis in women with previous gestational diabetes mellitus. Diabetes Care (2008) 0.91
Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. J Am Geriatr Soc (2013) 0.91
Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome. Obesity (Silver Spring) (2007) 0.90
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes. Diab Vasc Dis Res (2013) 0.89
Cystatin C as a marker of renal function immediately after liver transplantation. Liver Transpl (2006) 0.88
The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care (2005) 0.88
An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast. Diabetes Care (2007) 0.88
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension (2007) 0.88
Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men. J Hypertens (2007) 0.88
Local carotid stiffness and intima-media thickness assessment by a novel ultrasound-based system in essential hypertension. Atherosclerosis (2012) 0.87
The non-peptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity. Mol Cell Endocrinol (2009) 0.87
Hyperglycemia and vascular metabolic memory: truth or fiction? Curr Diab Rep (2013) 0.87
Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women. Diabetes Care (2005) 0.86
Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients. Rev Diabet Stud (2011) 0.86
Continually high insulin levels impair Akt phosphorylation and glucose transport in human myoblasts. Metabolism (2005) 0.86
Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients. Diabetes Care (2002) 0.86
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes. Diabetes Care (2009) 0.86
Optimal therapy of type 2 diabetes: a controversial challenge. Aging (Albany NY) (2014) 0.85
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. J Clin Endocrinol Metab (2013) 0.85
Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis (2002) 0.85
Physical activity and dietary habits during pregnancy: effects on glucose tolerance. J Matern Fetal Neonatal Med (2010) 0.85
Global call for free academic movement for international dialogue. Diabetes Care (2012) 0.85
Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients. Diabetes Metab Res Rev (2004) 0.84
Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells: evidence for differential glutathione peroxidase-1 expression. Microvasc Res (2010) 0.84
1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women. Int J Endocrinol (2012) 0.84
A simplified technique for the en bloc procurement of abdominal organs that is suitable for pancreas and small-bowel transplantation. Surgery (2004) 0.84
Early improvement of unstable diabetic retinopathy after solitary pancreas transplantation. Diabetes Care (2002) 0.83
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. Diabetes Care (2012) 0.83
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes. Diabetes Res Clin Pract (2007) 0.83
High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Res Clin Pract (2012) 0.83
Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief. Diabetes Care (2003) 0.83
Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation (2003) 0.82
The TOSCA.IT trial: a study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes. Diabetes Care (2012) 0.81
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. Diab Vasc Dis Res (2004) 0.81
Chlorthalidone improves endothelial-mediated vascular responses in hypertension complicated by nondiabetic metabolic syndrome. J Cardiovasc Pharmacol Ther (2005) 0.81
Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens (2008) 0.81
Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study. Gynecol Endocrinol (2010) 0.81